Submitted by Anonymous (not verified) on 5 February 2026 - 16:30
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eltrombopag Viatris, eltrombopag, Date of authorisation: 12/12/2024, Revision: 3, Status: Authorised